Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity

American Journal of Physiology - Cell Physiology

Volumn 295, Issue 5, 2008, Pages

  Smith, Paul J ^a   Wiltshire, Marie ^a   Furon, Emeline ^a   Beattie, John H ^b   Errington, Rachel J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cadmium; Flow cytometry; Metallothioneins; Two photon laser scanning microscopy; Zinquin

Indexed keywords

CADMIUM; METALLOTHIONEIN I; ZINC; ZINC ION;

ANIMAL CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; CYTOTOXICITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING;

ANIMALS; CADMIUM COMPOUNDS; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; CYTOPLASM; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; METALLOTHIONEIN; MICE; STRESS, PHYSIOLOGICAL; SULFATES; TIME FACTORS; TRANSFECTION; UP-REGULATION; ZINC SULFATE;

CRICETULUS GRISEUS;

EID: 57349106566     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00342.2008     Document Type: Article

References (62)

1. Apostolova MD, Cherian MG. Delay of M-phase onset by aphidicolin can retain the nuclear localization of zinc and metallothionein in 3T3-L1 fibroblasts. J Cell Physiol 183: 247-253, 2000.
2. Apostolova MD, Ivanova IA, Cherian MG. Signal transduction pathways, and nuclear translocation of zinc and metallothionein during differentiation of myoblasts. Biochem Cell Biol 78: 27-37, 2000.
3. + and amino acid transport and metallothionein (MT) induction. Neurotoxicology 17: 107-116, 1996.
4. Beattie JH, Owen HL, Wallace SM, Arthur JR, Kwun IS, Hawksworth GM, Wallace HM. Metallothionein overexpression and resistance to toxic stress. Toxicol Lett 157: 69-78, 2005.
5. Beyersmann D, Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol Appl Pharmacol 144: 247-261, 1997.
6. Cai L, Li XK, Song Y, Cherian MG. Essentiality, toxicology and chelation therapy of zinc and copper. Curr Med Chem 12: 2753-2763, 2005.
7. Chang YC, Liao CB, Hsieh PY, Liou ML, Liu YC. Expression of tumor suppressor p53 facilitates DNA repair but not UV-induced G2/M arrest or apoptosis in Chinese hamster ovary CHO-K1 cells. J Cell Biochem 103: 528-537, 2008.
8. Cherian MG, Apostolova MD. Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol (Noisy-le-grand) 46: 347-356, 2000.
9. 2+ homeostasis in neurons from experimental and modeling studies. Am J Physiol Cell Physiol 294: C726-C742, 2008.
10. Coyle P, Philcox JC, Carey LC, Rofe AM. Metallothionein: the multipurpose protein. Cell Mol Life Sci 59: 627-647, 2002.
11. Coyle P, Zalewski PD, Philcox JC, Forbes IJ, Ward AD, Lincoln SF, Mahadevan I, Rofe AM. Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc. Biochem J 303: 781-786, 1994.
12. Daniels WM, Hendricks J, Salie R, van Rensburg SJ. A mechanism for zinc toxicity in neuroblastoma cells. Metab Brain Dis 19: 79-88, 2004.
13. Garrett SH, Somji S, Todd JH, Sens MA, Sens DA. Differential expression of human metallothionein isoform I mRNA in human proximal tubule cells exposed to metals. Environ Health Perspect 106: 825-832, 1998.
14. Ho E, Courtemanche C, Ames BN. Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. J Nutr 133: 2543-2548, 2003.
15. Hu T, Miller CM, Ridder GM, Aardema MJ. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res 426: 51-62, 1999.
16. Jasani B, Campbell F, Navabi H, Schmid KW, Williams GT. Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J Pathol 184: 144-147, 1998.
17. Jasani B, Schmid KW. Significance of metallothionein overexpression in human tumours. Histopathology 31: 211-214, 1997.
18. Jin T, Lu J, Nordberg M. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 19: 529-535, 1998.
19. Kao FT, Puck TT. Genetics of somatic mammalian cells. VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc Natl Acad Sci USA 60: 1275-1281, 1968.
20. Klaassen CD, Liu J. Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. J Toxicol Sci 23, Suppl 2: 97-102, 1998.
21. Koizumi S, Suzuki K, Ogra Y, Yamada H, Otsuka F. Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene. Eur J Biochem 259: 635-642, 1999.
22. Kondo Y, Yanagiya T, Himeno S, Yamabe Y, Schwartz D, Akimoto M, Lazo JS, Imura N. Simian virus 40-transformed metallothionein null cells showed increased sensitivity to cadmium but not to zinc, copper, mercury or nickel. Life Sci 64: PL145-PL150, 1999.
23. Liang L, Fu K, Lee DK, Sobieski RJ, Dalton T, Andrews GK. Activation of the complete mouse metallothionein gene locus in the maternal deciduum. Mol Reprod Dev 43: 25-37, 1996.
24. Lin KA, Chen JH, Lee DF, Lin LY. Alkaline induces metallothionein gene expression and potentiates cell proliferation in Chinese hamster ovary cells. J Cell Physiol 205: 428-436, 2005.
25. Magda D, Lecane P, Wang Z, Hu W, Thiemann P, Ma X, Dranchak PK, Wang X, Lynch V, Wei W, Csokai V, Hacia JG, Sessler JL. Synthesis and anticancer properties of water-soluble zinc ionophores. Cancer Res 68: 5318-5325, 2008.
26. Maier H, Jones C, Jasani B, Ofner D, Zelger B, Schmid KW, Budka H. Metallothionein overexpression in human brain tumours. Acta Neuropathol (Berl) 94: 599-604, 1997.
27. Malavolta M, Costarelli L, Giacconi R, Muti E, Bernardini G, Tesei S, Cipriano C, Mocchegiani E. Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 69: 1043-1053, 2006.
28. Marquez N, Chappell SC, Sansom OJ, Clarke AR, Court J, Errington RJ, Smith PJ. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint. Oncogene 22: 7642-7648, 2003.
29. Marquez N, Chappell SC, Sansom OJ, Clarke AR, Teesdale-Spittle P, Errington RJ, Smith PJ. Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts. Cell Cycle 3: 662-671, 2004.
30. McCluggage WG, Maxwell P, Hamilton PW, Jasani B. High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 34: 51-55, 1999.
31. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 23: 783-792, 1997.
32. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 35: 35-70, 2000.
33. Nagel WW, Vallee BL. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci USA 92: 579-583, 1995.
34. Oliver JR, Jiang S, Cherian MG. Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide. Toxicol Appl Pharmacol 210: 190-199, 2006.
35. Oliver JR, Mara TW, Cherian MG. Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. Exp Biol Med (Maywood) 230: 61-67, 2005.
36. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci USA 95: 8428-8430, 1998.
37. Palmiter RD, Findley SD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 14: 639-649, 1995.
38. Potocnik FC, van Rensburg SJ, Hon D, Emsley RA, Moodie IM, Erasmus RT. Oral zinc augmentation with vitamins A and D increases plasma zinc concentration: implications for burden of disease. Metab Brain Dis 21: 139-147, 2006.
39. Reyes JG. Zinc transport in mammalian cells. Am J Physiol Cell Physiol 270: C401-C410, 1996.
40. Schwarz MA, Lazo JS, Yalowich JC, Reynolds I, Kagan VE, Tyurin V, Kim YM, Watkins SC, Pitt BR. Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J Biol Chem 269: 15238-15243, 1994.
41. Smith PJ, Blunt N, Wiltshire M, Hoy T, Teesdale-Spittle P, Craven MR, Watson JV, Amos WB, Errington RJ, Patterson LH. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 40: 280-291, 2000.
42. Smith PJ, Marquez N, Wiltshire M, Chappell S, Njoh K, Campbell L, Khan IA, Silvestre O, Errington RJ. Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle 6: 2071-2081, 2007.
43. Smith PJ, Wiltshire M, Chin SF, Rabbitts P, Soues S. Cell cycle checkpoint evasion and protracted cell cycle arrest in X-irradiated small-cell lung carcinoma cells. Int J Radiat Biol 75: 1137-1147, 1999.
44. Smith PJ, Wiltshire M, Davies S, Chin SF, Campbell AK, Errington RJ. DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells. Am J Physiol Cell Physiol 283: C609-C622, 2002.
45. Studer R, Vogt CP, Cavigelli M, Hunziker PE, Kagi JH. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem J 328: 63-67, 1997.
46. Tzang BS, Lai YC, Hsu M, Chang HW, Chang CC, Huang PC, Liu YC. Function and sequence analyses of tumor suppressor gene p53 of CHO.K1 cells. DNA Cell Biol 18: 315-321, 1999.
47. Tzang BS, Lai YC, Liu YC. UV-induced but P53 independent apoptotic death in CHO. K1 cells is promoted by M phase inhibitors. In Vitro Cell Dev Biol Anim 35: 17-18, 1999.
48. Vallee BL. Introduction to metallothionein. Methods Enzymol 205: 3-7, 1991.
49. Van Molle W, Van Roy M, Van Bogaert T, Dejager L, Van Lint P, Vanlaere I, Sekikawa K, Kollias G, Libert C. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy. Cancer Res 67: 7301-7307, 2007.
50. Vasak M. Advances in metallothionein structure and functions. J Trace Elem Med Biol 19: 13-17, 2005.
51. Waelput W, Broekaert D, Vandekerckhove J, Brouckaert P, Tavernier J, Libert C. A mediator role for metallothionein in tumor necrosis factor-induced lethal shock. J Exp Med 194: 1617-1624, 2001.
52. Wallace SM, Zaidi H, Arthur JR, Bremner I. Effect of zinc on metallothionein content of CHO cells transfected with metallothionein gene under the control of a non-inducible promoter. Biochem Soc Trans 24: 237S, 1996.
53. Wellinghausen N, Fischer A, Kirchner H, Rink L. Interaction of zinc ions with human peripheral blood mononuclear cells. Cell Immunol 171: 255-261, 1996.
54. 2+ resembles that of NO-mediated nitrosative stress and is protected by MT-1 overexpression. Am J Physiol Cell Physiol 291: C555-C568, 2006.
55. Wong SH, Shih RS, Schoene NW, Lei KY. Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells. Am J Physiol Cell Physiol 294: C1342-C1349, 2008.
56. Wong SH, Zhao Y, Schoene NW, Han CT, Shih RS, Lei KY. Zinc deficiency depresses p21 gene expression: inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells. Am J Physiol Cell Physiol 292: C2175-C2184, 2007.
57. Woo ES, Lazo JS. Nucleocytoplasmic functionality of metallothionein. Cancer Res 57: 4236-4241, 1997.
58. Woo ES, Monks A, Watkins SC, Wang AS, Lazo JS. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel. Cancer Chemother Pharmacol 41: 61-68, 1997.
59. Xie J, Shaikh ZA. Cadmium induces cell cycle arrest in rat kidney epithelial cells in G2/M phase. Toxicology 224: 56-65, 2006.
60. Yang PM, Chiu SJ, Lin KA, Lin LY. Effect of cadmium on cell cycle progression in Chinese hamster ovary cells. Chem Biol Interact 149: 125-136, 2004.
61. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p- toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296: 403-408, 1993.
62. Zalewski PD, Millard SH, Forbes IJ, Kapaniris O, Slavotinek A, Betts WH, Ward AD, Lincoln SF, Mahadevan I. Video image analysis of labile zinc in viable pancreatic islet cells using a specific fluorescent probe for zinc. J Histochem Cytochem 42: 877-884, 1994.